By Dr Karthiyayini Mahadevan, Head – Wellness and Wellbeing at Columbia Pacific Communities
India is already witnessing the third wave of COVID –19 and the daily cases are rising every day. Here are some precautions that one could to protect themselves from the omicron variant.
The Precautionary steps towards protection are:
2.At the community level
An individual’s health is in others’ hands. Our wellbeing is in the well-being of others. So, maintaining COVID appropriate behaviour such as wearing masks properly, maintaining social distance and hand hygiene is paramount.
3.At the country level
Strategies to enforce the completion of vaccination among the population by prioritising the vulnerable groups will allow us to investigate the possibilities of streamlining the booster dose.
4.At the global level
Efforts to support each other globally in bringing the pandemic under control such asstandardisation of vaccination, sharing the resources and studies to understand the need for the booster dose. This will help bring in better understanding about the virus in its mutated form and to view that as an agent to bring in herd immunity.
Vaccination for the age group of 15-18 years
With our present achievement in vaccination to cover majority of the18+population, India has started administrating vaccine against COVID-19 for age group of 15-18 years. The side effects are seen to be varying between just a local reaction as pain and swelling over the injection site or systemic reactions such as general exhaustion, body aches and fever. As warned for the other age groups, if one has any history of allergic reaction to any medication, they need to check with their family physician before vaccination.
Booster dose
Booster doses for senior citizens with co-morbidities and the frontline workers are being launched from January 10, 2022 in India. Third dose needs to be given 9-12 months after the second dose depending on the vaccine. The side effects expected from the booster dose include local pain over injection site, exhaustion, body ache and fever.
There are clinical trials with vaccines made to protect people specifically against the omicron variant and are administered as a booster dose, but it is still under study.
Corporate Comm India (CCI Newswire)
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…